⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17571272 | 0.70 | — | — | |
| SCHEMBL14748367 | 0.56 | — | — | |
| SCHEMBL14950230 | 0.54 | — | — | |
| SCHEMBL825033 | 0.47 | — | — | |
| SCHEMBL15159913 | 0.47 | — | — | |
| SCHEMBL15760191 | 0.47 | — | — | |
| SCHEMBL16125102 | 0.47 | — | — | |
| SCHEMBL14819207 | 0.47 | — | — | |
| SCHEMBL15453117 | 0.47 | — | — | |
| SCHEMBL56798 | 0.41 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160347801-A1 | PEPTIDES DERIVED FROM NCAPG2 AND THEIR USE | NATIONAL CANCER CENTER (KR) | 2016-12-01 | — | — | US | disclosed |